BASDAI CHANGES IN ANKYLOSING SPONDYLITIS PATIENTS TREATED WITH ANTI-TUMOUR NECROSIS FACTOR THERAPY

被引：0
|
作者：
Clarke, Laura [1 ,2 ]
Kay, Lesley [1 ,2 ]
机构：
[1] Newcastle Hosp NHS Fdn Trust, Musculoskeletal Unit, Newcastle Upon Tyne, Tyne & Wear, England
[2] Newcastle Univ, Sch Med, Newcastle Upon Tyne, Tyne & Wear, England
来源：
RHEUMATOLOGY | 2010年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：I58 / I59
页数：2
相关论文
共 50 条
  • [1] Anti-tumour necrosis factor a therapy for ankylosing spondylitis: international experience
    Braun, J
    Sieper, J
    Breban, M
    Collantes-Estevez, E
    Davis, J
    Inman, R
    Marzo-Ortega, H
    Mielants, H
    ANNALS OF THE RHEUMATIC DISEASES, 2002, 61 : 51 - 60
  • [2] Anti-tumour necrosis factor therapy for ankylosing spondylitis - unresolved issues
    Jois, R. N.
    Gaffney, K.
    Keat, A.
    RHEUMATOLOGY, 2007, 46 (06) : 899 - 901
  • [3] ANKYLOSING SPONDYLITIS: ANTI-TUMOUR NECROSIS FACTOR AND BEYOND
    Sengupta, Raj
    RHEUMATOLOGY, 2017, 56 : 10 - 10
  • [4] The inadequate anti-tumour necrosis factor (anti-TNF) therapy in patients with ankylosing spondylitis
    Pinar Borman
    Figen Ayhan
    Esma Ceceli
    Rheumatology International, 2010, 30 : 1689 - 1690
  • [5] The inadequate anti-tumour necrosis factor (anti-TNF) therapy in patients with ankylosing spondylitis
    Borman, Pinar
    Ayhan, Figen
    Ceceli, Esma
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (12) : 1689 - 1690
  • [6] Anti-tumour necrosis factor therapy in ankylosing spondylitis. A need for guidelines
    Kassimos, DG
    Garyfallos, A
    Delamere, J
    Whallett, A
    Kitas, GD
    RHEUMATOLOGY, 2003, 42 (03) : 490 - 490
  • [7] Immunogenicity of anti-tumour necrosis factor therapy in Korean patients with rheumatoid arthritis and ankylosing spondylitis
    Jung, Seung Min
    Kim, Hyun-Sook
    Kim, Hae-Rim
    Kim, Na Young
    Lee, Jung-Hwa
    Kim, Juryun
    Kwok, Seung-Ki
    Park, Kyung-Su
    Park, Sung-Hwan
    Kim, Ho-Youn
    Ju, Ji Hyeon
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 21 (01) : 20 - 25
  • [8] The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis
    Barkham, N
    Kong, KO
    Tennant, A
    Fraser, A
    Hensor, E
    Keenan, AM
    Emery, P
    RHEUMATOLOGY, 2005, 44 (10) : 1277 - 1281
  • [9] Structure-Modifying Capacity of Anti-Tumour Necrosis Factor-α Therapy in Ankylosing Spondylitis
    Filip De Keyser
    Dominique Baeten
    Filip Van den Bosch
    Elli Kruithof
    Gust Verbruggen
    Herman Mielants
    Eric Veys
    Drugs, 2004, 64 : 2793 - 2811
  • [10] Structure-modifying capacity of anti-tumour necrosis factor-α therapy in Ankylosing spondylitis
    De Keyser, F
    Baeten, D
    Van den Bosch, F
    Kruithof, E
    Verbruggen, G
    Mielants, H
    Veys, E
    DRUGS, 2004, 64 (24) : 2793 - 2811
12345